ArticleCancers2022

EMT, Stemness, and Drug Resistance in Biological Context: A 3D Tumor Tissue/In Silico Platform for Analysis of Combinatorial Treatment in NSCLC with Aggressive KRAS-Biomarker Signatures.

Matthias Peindl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.